Nestle buys Pfizer's baby food unit for $11.85bn

Be the first to comment
SMA: Pfizer baby product is bought by Nestle
SMA: Pfizer baby product is bought by Nestle

Nestle has agreed to buy Pfizer's baby food division for $11.85bn, increasing its hold on the Chinese market and boosting its dominance over French rival Danone.

The purchase of the division (announced today 23 April) will particuarly help to boost sales in China, where the company has lost market share in the past five years after withdrawing two varieties of its Neslac milk powder over concerns it contained excessive iodine.

Paul Bulcke, Nestle chief executive, said: "Pfizer Nutrition is an excellent strategic fit and this acquisition underlines our commitment to be the world’s leading nutrition, health and wellness company.

"The combined entities will enable us to deepen our engagement with consumers, offering them a wider choice of nutritious food to ensure their children make a healthy start to a healthy life."

Nestle is thought to have beaten Danone to the purchase of the unit, as the two companies grapple for pre-eminence in the lucrative baby food business.

The acquisition is subject to regulatory approval and is expected to be completed by 2013.

Pfizer's baby food division provides products, including infant formulas Promil and SMA as well as Enercal supplements for adults, to more than 60 countries.

The unit accounted for 3.2% of Pfizer's revenues in 2011, according to its financial accounts.

Currently, Pfizer lags behind Danone and Abbot Laboratories, among others, in the infant formula market.

Follow John Reynolds on Twitter @johnreynolds10


Only £53 for 3 months

Includes every print & iPad edition, plus full access to Campaign online and other Brand Republic sites


Campaign Jobs

Thousands of jobs across advertising, creative, marketing and media

Just published